EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms

Dates: October 12-14, 2017
Location: Budapest, Hungary
Chairs: C Harrison, JJ Kiladjian

EHA and the EHA Scientific Working Group on Myeloproliferative Neoplasms are organizing this EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms.

Below you will find key information and the links to important details regarding registration and accommodation and a wide array of sponsor opportunities available for pharmaceutical companies.


The scientific program will cover the following topics:

  • Molecular pathogenesis and diagnosis
  • State of the art: Novel therapies for MPN
  • Indolent MPN
  • What’s new in myelofibrosis?
  • Use of interferon in MPN
  • Mechanisms of resistance to JAK inhibitors
  • Patient advocacy in EU
  • Prognostic scores in MPN
  • Advances in systemic mastocytosis
  • Advances in diagnosis and management of CMML
  • State of the art: Investigation and management of erythrocytosis

For a complete overview of the scientific program, click here.

Learning Objectives

After attending the meeting, participants will be able to:

  • Identify key clinical and scientific advances in MPN 
  • Facilitate better collaboration between clinical and scientific MPN communities 
  • Facilitate formal debate in 2 controversial areas: e.g. Treatment of early MF or not
  • Incorporate clinical cases to illustrate challenges and share learning 
  • Promote discussion about the need for development of guidelines To encourage the development of young scientists and clinicians in this field
  • Engage with the patient community regarding models of care, advocacy and scientific research
  • Publish a meeting report of key learning points

EHA-SWG Promotional video

interviewInterview with Prof Harrison and Prof Kiladjian about the EHA-SWG Scientific Meeting.


The meeting will take place at the Novotel Budapest City
Alkotás u. 63
1123 Budapest, Hungary

Key dates

Sponsor Acknowledgements

This meeting is supported by:

Premium level partner

resizedimage23040 Novartis.svg PNG 

Major level partner


Conference partner

resizedimage200150 Janssen logo and jandj logo 1024x768 

Conference supporter

resizedimage175147 Incyte Logo 

Sponsorship opportunities

For support opportunities, click here.

EBAH CME Accreditation

EBAH accredited stamp DEF2

Continuing Medical Education (CME) is widely accepted as a means to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.